Combined Effect of TLR2 Ligands on ROS Production by Mouse Peritoneal Macrophages
- 作者: Teselkin Y.O.1, Khoreva M.V.1, Veselova A.V.1, Babenkova I.V.1, Osipov A.N.1, Gankovskaya L.V.1, Vladimirov Y.A.1
- 
							隶属关系: 
							- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
 
- 期: 卷 166, 编号 1 (2018)
- 页面: 26-30
- 栏目: Biophysics and Biochemistry
- URL: https://journals.rcsi.science/0007-4888/article/view/240806
- DOI: https://doi.org/10.1007/s10517-018-4281-9
- ID: 240806
如何引用文章
详细
TLR2-mediated ROS production by mouse peritoneal macrophages was studied by luminoldependent chemiluminescence under conditions of cell stimulation with zymosan (TLR2/6 ligand) and peptidoglycan (TLR2/1 ligand). ROS production by macrophages stimulated with zymosan and peptidoglycan simultaneously depended on the ratio of ligand concentrations. Three effects were revealed: additivity of the stimulating effects of the ligands used, competitive ligand binding, and effect of macrophage priming with peptidoglycan during cell stimulation with zymosan. The mechanisms of these effects are discussed.
作者简介
Yu. Teselkin
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
							编辑信件的主要联系方式.
							Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
M. Khoreva
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
														Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
A. Veselova
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
														Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
I. Babenkova
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
														Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
A. Osipov
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
														Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
L. Gankovskaya
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
														Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
Yu. Vladimirov
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
														Email: teselkin-box@mail.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					